Back to search results

Centralized Screening Unit (CSU) for Lung Cancer Screening at Montefiore-Einstein

This study is testing a new way to help more people in the Bronx get screened for lung cancer. It's called the Centralized Screening Unit (CSU) and it aims to make it easier for people to get the low-dose computed tomography (LDCT) scan, which can find lung cancer early. The CSU will identify eligible patients, contact them, provide education and support, and help them get referred for screening and follow-up care. We want to see if this approach increases the number of people who get screened and if it helps find more cases of early-stage lung cancer. You may be able to join if you are between 50 and 77 years old, are a current or past smoker with a significant smoking history, and meet other specific health criteria. The study plans to enroll 9460 participants.

Study design
This is an interventional study, meaning participants will receive a specific intervention (the CSU program). It aims to enroll 9460 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for approximately 2.5 years to measure referrals and the proportion of early-stage lung cancer cases.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06284408

Centralized Screening Unit (CSU) at Montefiore-Einstein

Recruiting
NAAges 50–77InterventionalHealth services
Albert Einstein College of Medicine
~9,460 participants
Updated 2026-01-23 on ClinicalTrials.gov
What's tested:Centralized Screening Unit Implementation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Participant Referrals
Measured over Approximately 2.5 years
+1 more outcome measured

Conditions

Lung Cancer

Explore related trials

Lung Carcinoma

Where it's being run

1 sites across 1 states
New York1

Study leadership

  • H. Dean Hosgood, PhD · PRINCIPAL_INVESTIGATOR · Albert Einstein College of Medicine

Who to contact

H. Dean Hosgood, PhD
[email protected]
203-215-3275
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

a NYC RING affiliated clinic,
Opt into and agree to research protocol;
Age 50-77 for participants,
past or current smoker,
20+ pack-years tobacco,
has quit smoking within the last 15 years,
without chest CT within the past 12 months, and,
no history of lung cancer or and at least 5 years since the diagnosis of any other malignancy

Exclusion

only treats pediatric patients,
Opt out of research protocol;
Primary care provider instruction to not contact an individual for any reason. Any individual inadvertently contacted who does not meet these criteria will be excluded from the study.

What this trial measures

  • Participant ReferralsApproximately 2.5 years

    The number of participant referrals by clinician for LCS by the CSU versus the number of clinician referrals will be assessed and reported.

  • Proportion of participants with early stage lung cancer (LCa)Approximately 2.5 years

    The proportion of participants with early stage LCa disease (for the purposes of this study defined as any Stage 1 or Stage 2 LCa) amongst those who received LCS during the study period compared to those diagnosed in the general Einstein-Montefiore population during the same time period, including the 11 NYC RING clinics not in the trial, and the preceding 7 years (i.e., since LDCT has been available at MMC) will be assessed and reported.